Microbial Imbalance in Autoimmune Disease
Emerging evidence is placing the gut microbiome at the centre of autoimmune disease research, with growing implications for systemic lupus erythematosus (SLE). A recent review highlights how disruptions in gut microbial composition may contribute to immune dysregulation, chronic inflammation, and disease progression. Patients with autoimmune diseases consistently demonstrate reduced microbial diversity alongside significant compositional changes, suggesting that the microbiome may play a more active role in disease biology than previously thought.
Key Bacterial Players in Lupus
Specific microbial species have been linked to immune dysregulation. In lupus, Ruminococcus gnavus has been associated with disease flares, while other species such as Prevotella copri contribute to broader inflammatory pathways. These findings point towards a potential microbial signature that could reflect or even predict disease activity.
How the Gut Drives Immune Activation
Disrupted gut microbiota may actively trigger autoimmune responses through several mechanisms. Impaired intestinal barrier function can allow microbial components to enter circulation, promoting systemic inflammation. Molecular mimicry—where bacterial antigens resemble host tissues—may further drive the autoimmune attack seen in lupus. Additionally, altered production of microbial metabolites, including short-chain fatty acids and tryptophan derivatives, can influence immune signalling pathways central to disease progression.
Impact on Treatment Response
The gut microbiome may also shape how patients respond to lupus therapies. By influencing drug metabolism, gut bacteria can affect both the efficacy and toxicity of immunosuppressive treatments, highlighting the importance of considering microbiota in personalised care strategies.
Future Directions: Microbiome-Targeted Therapies
Clinically, profiling the gut microbiota may support earlier diagnosis and improved prediction of disease course. At the same time, microbiome-targeted interventions, including probiotics, dietary modification, and faecal microbiota transplantation, are being explored as potential adjunctive strategies in lupus care.
Reference
Zeng L et al. The Gut Microbiota: Emerging Evidence in Autoimmune and Inflammatory Diseases. Research (Wash D C). 2026;9:1097.
Featured Image:
